Karl Landsteiner was an Austrian-born physician and immunologist whose discovery of human blood groups made safe blood transfusions possible. Born in Vienna on June 14, 1868, he spent his career unraveling how the immune system distinguishes between “self” and “foreign,” work that earned him the 1930 Nobel Prize in Physiology or Medicine.
Early Life and Education
Landsteiner grew up in Vienna and studied medicine at the University of Vienna, graduating in 1891 at age 23. After earning his degree, he spent several years working in chemistry and pathology laboratories across Europe, building a foundation in both bench science and clinical medicine that would shape his later research. His early interest in how the body’s immune defenses interact with foreign substances led him toward the question that would define his career: why do blood transfusions sometimes kill people?
Discovery of ABO Blood Groups
Before Landsteiner’s work, blood transfusions were essentially a gamble. Some patients recovered; others suffered violent reactions and died. No one could reliably explain why. Starting in 1900, Landsteiner began systematically mixing blood samples from different individuals and observing what happened. He noticed that in certain combinations, red blood cells clumped together, a process called agglutination. In other combinations, the blood mixed smoothly.
By 1901, he had worked out the reason. An interaction between red blood cells and antibodies in blood serum caused the clumping, and the pattern wasn’t random. He identified three distinct blood groups: A, B, and O. A fourth group, AB, was identified shortly after by his colleagues. These four types, now known as the ABO blood group system, explained why transfusions failed when incompatible blood types were mixed. For the first time, doctors had a way to test and match blood before a transfusion, transforming what had been a desperate last resort into a reliable medical procedure.
Polio Virus Research
Blood groups weren’t Landsteiner’s only major contribution. In 1908, working with colleague Erwin Popper, he demonstrated that poliomyelitis could be transmitted from humans to primates, proving the disease was caused by an infectious agent. At a meeting of the Royal and Imperial Association of Physicians in Vienna on December 18 of that year, Landsteiner reported the successful experimental transmission. He went on to describe the polio pathogen as a “filterable micro-organism,” meaning it was small enough to pass through filters that would catch bacteria. This was a critical early step toward understanding viruses as a distinct category of infectious agents and laid groundwork for the eventual development of polio vaccines decades later.
Work on Immune Specificity
Throughout his career, Landsteiner was deeply interested in how the immune system recognizes specific molecules. He pioneered research on what are now called haptens, small chemical compounds that can trigger an immune response when attached to a larger molecule like a protein. His experiments showed that the immune system could distinguish between molecules with remarkably subtle structural differences, such as the same chemical group attached at different positions on a molecule. This work helped establish the field of immunochemistry and provided foundational knowledge about how allergic reactions, autoimmune diseases, and immune responses work at a molecular level.
Career at the Rockefeller Institute
After World War I, economic hardship in Austria made research increasingly difficult. Landsteiner moved to The Hague in the Netherlands, where he worked as a pathologist at a small hospital. In 1922, he accepted a position at the Rockefeller Institute for Medical Research in New York City, where he would spend the most productive years of his later career. Much of his continued work on blood groups and immune specificity was conducted there. He officially retired in 1939 but never actually stopped working. On June 24, 1943, he suffered a heart attack in his laboratory and died two days later at age 75.
The Rh Factor
Even after his Nobel Prize, Landsteiner continued making discoveries. In the late 1930s, working with colleagues Alexander Wiener and Philip Levine, he identified the Rh factor, another protein on the surface of red blood cells that varies between individuals. The Rh factor explains why some pregnancies become dangerous: when an Rh-negative mother carries an Rh-positive baby, her immune system can attack the baby’s blood cells. Understanding this mechanism eventually led to preventive treatments that have saved countless newborn lives. This work earned Landsteiner and his collaborators a posthumous Lasker Clinical Medical Research Award in 1946.
Nobel Prize and Legacy
The Nobel Prize in Physiology or Medicine was awarded to Landsteiner in 1930 “for his discovery of human blood groups.” His ABO classification system remains the cornerstone of transfusion medicine more than a century later. Every blood donation worldwide is typed using the system he developed. His birthday, June 14, is observed as World Blood Donor Day.
Landsteiner’s influence extends well beyond blood banking. His research on immune specificity shaped how scientists understand allergies, organ transplant rejection, and autoimmune conditions. His demonstration that the polio pathogen was a filterable virus contributed to the broader understanding of viral diseases. Across immunology, virology, and transfusion medicine, the questions he asked and the methods he used continue to underpin modern practice.